Bozeman Daily Chronicle
Alzheimer’s drug gets FDA nod but hurdles remain
http://www.bozemandailychronicle.com offers audio versions of articles using Instaread. Some words may be mispronounced. Eisai Co. and Biogen Inc.’s Alzhiemer’s ...
Yahoo Finance
Acadia Gets FDA's Fast Track Tag for Alzheimer's Disease Candidate
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Forbes
Alzheimer’s Treatment Leqembi Gains New FDA Approval For Easier Dosing
Thank you for submitting your question. Keep reading Forbes Advisor for the chance to see the answer to your question in one of our upcoming stories. Our editors also may be in touch with follow-up ...
Washington Post
An experimental Alzheimer's drug shows promise targeting a different brain protein, new study shows
WASHINGTON — An experimental drug might help slow early Alzheimer’s disease in a markedly different way than today’s treatments — by lowering levels of a brain protein called tau, researchers reported ...
techtimes
Alzheimer’s Drug Kisunla Cuts ARIA Risk Nearly in Half, Two-Year Benefit Holds
On the final day of the 2026 Alzheimer's Association International Conference (AAIC) in London, the most complete safety and durability dataset yet assembled for Eli Lilly's Alzheimer's therapy ...
Hosted on MSN
Acadia gets FDA's fast track tag for Alzheimer's disease candidate
Acadia Pharmaceuticals ACAD announced that the FDA has granted Fast Track designation to its investigational, highly selective, 5-HT2A receptor inverse agonist, remlifanserin, for the treatment of ...